Both in Biotechnology
Maze Therapeutics vs ADMA Biologics
Over the past year MAZE returned +1.8% and ADMA returned −28.4%; their daily moves had a correlation of 0.35.
MAZE +1.8% ADMA −28.4%Growth of $1, one year, split-adjusted
| Metric | MAZE | ADMA |
|---|---|---|
| Price | $31.56 | $11.17 |
| Market cap | $1.75B | $2.50B |
| Today | −0.43% | −0.04% |
| 1 month | +16.8% | +12.1% |
| 6 months | +22.9% | +5.3% |
| Year to date | −23.8% | −38.8% |
| 1 year | +1.8% | −28.4% |
| Revenue growth (YoY) | — | +2.0% |
| Gross margin | — | 69.4% |
| Net margin | — | 30.4% |
| P/E (TTM) | — | 14.8× |
| Price / sales | 87.6× | 4.9× |
| Net cash | $372.1M | -$60.6M |
| Dividend yield | — | — |
| Volatility (60d) | 66.8% | 40.9% |
| Short % of float | 18.8% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).